BR100 Decreased By (-0%)
BR30 Decreased By (-0.12%)
KSE100 Increased By (0.35%)
KSE30 Increased By (0.3%)
BECO 6.09 Increased By ▲ 0.06 (1%)
BML 56.89 Increased By ▲ 4.14 (7.85%)
BOP 34.24 Decreased By ▼ -0.01 (-0.03%)
CNERGY 8.23 Increased By ▲ 0.07 (0.86%)
DCL 12.17 Decreased By ▼ -0.17 (-1.38%)
FCCL 54.27 Increased By ▲ 0.38 (0.71%)
FCSC 5.20 Decreased By ▼ -0.02 (-0.38%)
FFL 18.13 Increased By ▲ 0.10 (0.55%)
FNEL 1.30 No Change ▼ 0.00 (0%)
HUMNL 11.22 Increased By ▲ 0.22 (2%)
KEL 8.14 Increased By ▲ 0.03 (0.37%)
KOSM 5.44 Increased By ▲ 0.06 (1.12%)
MLCF 89.05 Increased By ▲ 1.00 (1.14%)
NBP 186.70 Increased By ▲ 0.22 (0.12%)
PACE 10.73 Increased By ▲ 0.01 (0.09%)
PAEL 40.39 Increased By ▲ 0.45 (1.13%)
PIAHCLA 26.34 Increased By ▲ 0.17 (0.65%)
PIBTL 17.45 Increased By ▲ 0.13 (0.75%)
PPL 233.39 Increased By ▲ 0.61 (0.26%)
PRL 34.94 Decreased By ▼ -0.01 (-0.03%)
PTC 66.96 Decreased By ▼ -0.60 (-0.89%)
SEARL 91.25 Increased By ▲ 0.32 (0.35%)
SSGC 27.13 Decreased By ▼ -0.04 (-0.15%)
TELE 8.58 Increased By ▲ 0.01 (0.12%)
THCCL 65.00 Increased By ▲ 4.87 (8.1%)
TPLP 9.10 Increased By ▲ 0.34 (3.88%)
TREET 24.81 Increased By ▲ 0.27 (1.1%)
TRG 73.18 Increased By ▲ 1.43 (1.99%)
WAVES 10.50 Increased By ▲ 0.52 (5.21%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
World

GSK raises $1.24bn from latest Haleon stake sale

Published January 17, 2024 Updated January 17, 2024 12:25pm
By

British drugmaker GSK said on Wednesday it had raised 978 million pounds ($1.24 billion) from a discounted stake sale in Haleon, cutting its shareholding to 4.2% in the world’s largest standalone consumer healthcare firm.

GSK says blood cancer drug meets primary goal in late-stage trial

GSK sold around 300 million shares in its spun-off unit at a price of 326 pence per share.

Comments

Comments are closed for this article.